Skip to main content

Home
Specialties
Resources

Search Videos and More

search

Channel Categories

Breast Cancer (25)
Cancer Screening and Survivorship (18)
Cell Therapy (43)
Clinical Trials (35)
COVID-19 (11)
Gastrointestinal Cancer (30)
Genitourinary Cancer (20)
Gynecologic Oncology (22)
Head and Neck Cancer (29)
Hematologic Oncology (70)
Immunotherapy (45)
Neuro-Oncology (12)
Pediatric Hematology/Oncology (10)
Primary Care (24)
Radiation Oncology (23)
Skin Cancer (15)
Surgical Oncology (6)
Thoracic Cancer (28)
Young Adult Malignancies (10)

Types

News (148)
Document (2)
CME Course (9)
Symposium (7)
Video Asset (149)

Showing 121 - 132 of 315 results

Previous| 1... 10 | 11 | 12 ...27 |Next

When Cancer Looks Like Something Else: How Does Mutational Profiling Inform the Diagnosis of Myelodysplasia?

When Cancer Looks Like Something Else: How Does Mutational Profiling Inform the Diagnosis of Myelodysplasia?

Hormone Replacement Therapy in Cancer Survivors

Hormone Replacement Therapy in Cancer Survivors

Roswell Park Experts Provide Nerve Surgery for Pain Relief, Muscle Restoration

Roswell Park Experts Provide Nerve Surgery for Pain Relief, Muscle Restoration

Tumor-Infiltrating Lymphocyte Therapy Tackles Treatment Blind Spot in Advanced Melanoma

Tumor-Infiltrating Lymphocyte Therapy Tackles Treatment Blind Spot in Advanced Melanoma

Clinical CAR T-cell Trial for Multiple Myeloma Suggests Possible “Cure”

Clinical CAR T-cell Trial for Multiple Myeloma Suggests Possible “Cure”

Surgical Management of Pancreas Cancer

Surgical Management of Pancreas Cancer

Advanced Noninvasive, Nonsurgical Prostate Cancer Treatment Now Available at Roswell Park

Advanced Noninvasive, Nonsurgical Prostate Cancer Treatment Now Available at Roswell Park

Thyroid Cancer

FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.

FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.

Roswell Park Will Lead $13.5M Effort to Understand Racial Disparities in Response to Immune Checkpoint Inhibitors

Roswell Park Will Lead $13.5M Effort to Understand Racial Disparities in Response to Immune Checkpoint Inhibitors

Roswell Park’s Dr. Pawel Kalinski to Lead $14.5M NCI-Funded Immunotherapy Effort

Roswell Park’s Dr. Pawel Kalinski to Lead $14.5M NCI-Funded Immunotherapy Effort

Clinical Trial Evaluates New Targeted Therapy for KRAS G12c-mutant Lung Cancer and Other Malignancies

Clinical Trial Evaluates New Targeted Therapy for KRAS G12c-mutant Lung Cancer and Other Malignancies

Showing 121 - 132 of 315 results

Previous| 1... 10 | 11 | 12 ...27 |Next

BROADCASTMED
BroadcastMed Privacy Policy

Medical Disclaimer